Skip to main content

Table 1 Baseline characteristics of analyzed patients

From: Spirulina platensis versus silymarin in the treatment of chronic hepatitis C virus infection. A pilot randomized, comparative clinical trial

Characteristic

Spirulina treated Group (n = 30)

Silymarin treated group (n = 29)

Age-yr (mean ± SD)

47 ± 12

48 ± 12

Sex - M/F

21/9

18/11

Body mass index

29.8 ± 6.2

29.7 ± 6.8

Baseline HCV RNA (log10 IU/mL): median (Q1-Q3)

5.35 (4.84-6.07)

5.43 (4.94-6.02)

Baseline ALT: median (Q1-Q3)

76 (44-106)

75 (43-108)

Baseline Child-Pugh score: mean(SD)

7.067 (1.28)

7 (1.25)

Interferon history:

(Naive/Relapser/Non-responder)

23/3/4

20/3/6